TY - JOUR
T1 - Consensus Quality Measures and Dose Constraints for Rectal Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology (ASTRO) Expert Panel
AU - Park, John
AU - Venkatesulu, Bhanu Prasad
AU - Kujundzic, Ksenija
AU - Katsoulakis, Evangelia
AU - Solanki, Abhishek A.
AU - Puckett, Lindsay L.
AU - Kapoor, Rishabh
AU - Chapman, Christina H.
AU - Hagan, Michael
AU - Kelly, Maria D.
AU - Palta, Jatinder
AU - Ashman, Jonathan B.
AU - Jacqmin, Dustin
AU - Kachnic, Lisa A.
AU - Minsky, Bruce D.
AU - Olsen, Jeffrey
AU - Raldow, Ann C.
AU - Wo, Jennifer Y.
AU - Dawes, Samantha
AU - Wilson, Emily
AU - Kudner, Randi
AU - Das, Prajnan
N1 - Publisher Copyright:
© 2022
PY - 2022/9/1
Y1 - 2022/9/1
N2 - Purpose: Ensuring high quality, evidence-based radiation therapy for patients with cancer is of the upmost importance. To address this need, the Veterans Affairs (VA) Radiation Oncology Program partnered with the American Society for Radiation Oncology and established the VA Radiation Oncology Quality Surveillance program. As part of this ongoing effort to provide the highest quality of care for patients with rectal cancer, a blue-ribbon panel comprised of rectal cancer experts was formed to develop clinical quality measures. Methods and Materials: The Rectal Cancer Blue Ribbon panel developed quality, surveillance, and aspirational measures for (a) initial consultation and workup, (b) simulation, treatment planning, and treatment, and (c) follow-up. Twenty-two rectal cancer specific measures were developed (19 quality, 1 aspirational, and 2 surveillance). In addition, dose-volume histogram constraints for conventional and hypofractionated radiation therapy were created. Conclusions: The quality measures and dose-volume histogram for rectal cancer serves as a guideline to assess the quality of care for patients with rectal cancer receiving radiation therapy. These quality measures will be used for quality surveillance for veterans receiving care both inside and outside the VA system to improve the quality of care for these patients.
AB - Purpose: Ensuring high quality, evidence-based radiation therapy for patients with cancer is of the upmost importance. To address this need, the Veterans Affairs (VA) Radiation Oncology Program partnered with the American Society for Radiation Oncology and established the VA Radiation Oncology Quality Surveillance program. As part of this ongoing effort to provide the highest quality of care for patients with rectal cancer, a blue-ribbon panel comprised of rectal cancer experts was formed to develop clinical quality measures. Methods and Materials: The Rectal Cancer Blue Ribbon panel developed quality, surveillance, and aspirational measures for (a) initial consultation and workup, (b) simulation, treatment planning, and treatment, and (c) follow-up. Twenty-two rectal cancer specific measures were developed (19 quality, 1 aspirational, and 2 surveillance). In addition, dose-volume histogram constraints for conventional and hypofractionated radiation therapy were created. Conclusions: The quality measures and dose-volume histogram for rectal cancer serves as a guideline to assess the quality of care for patients with rectal cancer receiving radiation therapy. These quality measures will be used for quality surveillance for veterans receiving care both inside and outside the VA system to improve the quality of care for these patients.
UR - http://www.scopus.com/inward/record.url?scp=85137137662&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85137137662&partnerID=8YFLogxK
U2 - 10.1016/j.prro.2022.05.005
DO - 10.1016/j.prro.2022.05.005
M3 - Article
C2 - 35907764
AN - SCOPUS:85137137662
SN - 1879-8500
VL - 12
SP - 424
EP - 436
JO - Practical radiation oncology
JF - Practical radiation oncology
IS - 5
ER -